Your browser does not support JavaScript!
COVID-19 : Découvrez les Plans de Continuité d’Activité des entreprises de l’environnement

Santé humaine biotechnologies domaine d'application

505 entreprises et organismes intervenants dans le domaine 'Santé humaine', classés par activité.

Rejoignez la communauté
Trouvez du matériel
Une actualité de FierceBiotech a été ajouté(e)
Hier à 14:05
COVID-19 prompts Pfizer to stop enrollment in most studies
Pfizer has paused enrollment in many new and ongoing clinical trials in response to the COVID-19 pandemic, Reuters reports. The action sees Pfizer join Bristol Myers Squibb and Eli Lilly on the list...
www.fiercebiotech.com
2 entreprise(s)
SANOFI AVENTIS
est cité dans une actualité de FierceBiotech
Il y a 3 jours
Novavax flu vaccine matches and beats Sanofi rival in phase 3
Novavax’s influenza vaccine NanoFlu has outperformed Sanofi’s Fluzone Quadrivalent on measures of immunogenicity in a phase 3 trial. The trial hit its primary and key secondary endpoints, sending...
www.fiercebiotech.com
LILLY FRANCE
est cité dans une actualité de Labiotech.eu
Il y a 3 jours
Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s disease drug has increased in worth by €38M with a new milestone payment. AC Immune and Eli Lilly modified a deal...
www.labiotech.eu
LILLY FRANCE
est cité dans une actualité de FierceBiotech
Il y a 4 jours
Eli Lilly offers drive-thru COVID-19 testing to Indianapolis docs, nurses
Eli Lilly detailed its plans to offer drive-through COVID-19 testing out of its Indianapolis headquarters—starting today for healthcare providers within the community....
www.fiercebiotech.com
LILLY FRANCE
est cité dans une actualité de FierceBiotech
Il y a 1 semaine
Eli Lilly opens labs, plans drive-thrus to help boost Indiana's COVID-19 testing capacity
Eli Lilly is opening the doors of its Indianapolis headquarters to help the state health department process samples for the novel coronavirus outbreak....
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Il y a 1 semaine
EuroBiotech Report—BioNTech, Pfizer advance COVID-19 plan, Novartis data and OncoOne round
In this week's EuroBiotech Report, BioNTech and Pfizer advance COVID-19 plan, Novartis posts inclisiran data and ex-Shire researchers raise cash....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 1 semaine
Merck hits goal in cough phase 3 but yet to quash tolerability concern
Merck has linked gefapixant to statistically significant improvements in chronic cough patients in two phase 3 trials. The results cement Merck’s status as the front-runner in the race to develop a...
www.fiercebiotech.com
SANOFI AVENTIS
est cité dans une actualité de L'Usine Nouvelle
Il y a 1 semaine
Sanofi et Regeneron lancent un essai clinique pour tester un de leurs traitements contre le Covid-19
Le géant pharmaceutique français Sanofi et son partenaire américain Regeneron vont tester leur médicament Kevzara dans le traitement du Covid-19.... - L'Usine Santé
www.usinenouvelle.com
LILLY FRANCE
est cité dans une actualité de FierceBiotech
Il y a 1 semaine
Lilly taps AbCellera to get coronavirus drug into clinic in 4 months
Eli Lilly has teamed up with AbCellera to develop a treatment for the novel coronavirus. The partners aim to have an antibody in the clinic within four months, giving them a shot at contributing to...
www.fiercebiotech.com
SANOFI AVENTIS
est cité dans une actualité de FierceBiotech
Il y a 1 semaine
Enanta Pharmaceuticals joins the hunt for coronavirus treatments
The hunt is on for a treatment against COVID-19, the disease caused by the novel coronavirus circulating the globe. Some players, like Sanofi and Regeneron, are repurposing older drugs, while others...
www.fiercebiotech.com
Charger plus d'actualités